Details for New Drug Application (NDA): 085686
✉ Email this page to a colleague
NDA 085686 describes CURRETAB, which is a drug marketed by Solvay and is included in one NDA. Additional details are available on the CURRETAB profile page.
The generic ingredient in CURRETAB is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
The generic ingredient in CURRETAB is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 085686
| Tradename: | CURRETAB |
| Applicant: | Solvay |
| Ingredient: | medroxyprogesterone acetate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085686
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
